| CAS No.: | 147098-20-2 |
|---|---|
| Formula: | C16h20fn3o3s |
| EINECS: | 604-563-9 |
| Type: | Synthesis Material Intermediates |
| Appearance: | Powder |
| Quality: | Industrial |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name | USA UK Warehouse Antihyperlipidemic Drug Rosuvastatin Calcium CAS 147098-20-2 Rosuvastatin Calcium |
| CAS | 147118-36-3 |
| Assay | 99%min, 98.0% --101.0% |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
|
What is Rosuvastatin Calcium ? Rosuvastatin calcium is an anti-hyperlipidemia drug, a HMG-CoA reductase inhibitor, developed by Astrazeneca in the United Kingdom for the treatment of a variety of lipid abnormalities, including hypercholesterolemia, mixed lipid dysplasia and pure hypertriglyceridemia. Rosuvastatin calcium is a statin with the strongest lipid-lowering effect and the most comprehensive lipid-regulating effect among the currently listed lipid-lowering drugs. Compared with atorvastatin, which is currently recognized as the world's most effective. |
A new generation of statin lipid-lowering drugs, which are HMG-CoA reductase inhibitors, can reduce elevated
low-density cholesterol, total cholesterol, triglycerides, and apoprotein B concentrations, while increasing the
concentration of high-density cholesterol. It can be used for the comprehensive treatment of primary hypercholesterolemia,
mixed lipodystrophy and homozygous familial hypercholesterolemia.
USA UK Warehouse Antihyperlipidemic Drug Rosuvastatin Calcium CAS 147098-20-2 Rosuvastatin Calcium
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}